Ad blocking detected

Thank you for visiting CanadianInsider.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Club
$299/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads
JOIN THE CLUB

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

Globe Newswire News Releases

Sep 25, 2020 06:00 ET
Aesthetic Medical International Holdings Group Limited Reports Second Quarter 2020 Unaudited Financial Results
Aesthetic Medical International Holdings Group Limited (the “Company” or Nasdaq: AIH), a leading provider of aesthetic medical services in China, today announces its unaudited financial results for the second quarter ended June 30, 2020. Dr....
Sep 25, 2020 06:00 ET
Genetron Health and CStone Pharmaceuticals Announce Launch of Clinical Trial in China for Companion Diagnostic Test in Development for Avapritinib
Genetron Holdings Limited (“Genetron Health”, Nasdaq: GTH), a leading precision oncology platform company in China that specializes in offering molecular profiling tests, early cancer screening products and companion diagnostics development, and...
Sep 25, 2020 06:00 ET
Johnson Outdoors Announces Cash Dividend Increase
Johnson Outdoors Inc. (Nasdaq:JOUT), a leading global innovator of outdoor recreation equipment and technology, today announced approval by its Board of Directors of an increased quarterly cash dividend. Class A shareholders will now receive a...
Sep 25, 2020 06:00 ET
RETRANSMISSION - MEDIA AVAILABILITY: CN Police officers available for media interviews during Rail Safety Week
CN (TSX: CNR) (NYSE: CNI) is offering members of the media the opportunity to talk with uniformed police officers during Rail Safety Week, from September 21-27, about the importance of rail safety at crossings and the dangers of trespassing....
Sep 25, 2020 06:00 ET
RETRANSMISSION - MEDIA AVAILABILITY: CN Police officers available for media interviews during Rail Safety Week
CN (TSX: CNR) (NYSE: CNI) is offering members of the media the opportunity to talk with uniformed police officers during Rail Safety Week, from September 21-27, about the importance of rail safety at crossings and the dangers of trespassing....
Sep 25, 2020 05:30 ET
Opthea Files Registration Statement for Proposed Initial Public Offering in the United States
Opthea Limited (ASX:OPT), a clinical stage biopharmaceutical company developing a novel therapy to treat highly prevalent and progressive retinal diseases, today announces the public filing of a registration statement on Form F-1 with the U.S....
Sep 25, 2020 03:06 ET
Orphazyme A/S provides update on previously announced global offering
Orphazyme A/SCompany announcement                                                                                       No. 54/2020                                                                                                          Company...
Sep 25, 2020 03:01 ET
Victory Square Technologies Portfolio Company Acquires Brazilian Manufacturing & Laboratory Facility to Increase Production of its Covid-19 Testing Products by an additional 4,000,000 Units in Brazil
Victory Square Health Inc. (“VS Health” or the “Company”) – a portfolio company of Victory Square Technologies Inc. (“Victory Square”) (CSE:VST) (OTC:VSQTF) (FWB:6F6) – has entered into an agreement on September 24, 2020 to acquire a certified...
Sep 25, 2020 03:00 ET
Fortem Technologies Announces Webinar with INTERPOL: Safely Defeating Urban Drone Threats
Fortem Technologies, a leader in airspace security and defense for detecting and defeating dangerous drones, will be holding a free webinar on the topic of the challenges for counter UAS and drone defense for audiences across Western Europe, The...
Sep 25, 2020 02:00 ET
Tiziana Life Sciences Interview to Air on Bloomberg International on The RedChip Money Report
Tiziana Life Sciences plc (Nasdaq: TLSA / AIM: TILS) ("Tiziana" or the "Company"), a biotechnology company focused on innovative therapeutics for oncology, inflammation and infectious diseases, today announced an interview with Dr. Kunwar...
Sep 25, 2020 02:00 ET
Dansk Kabel TV signs with Agillic and boosts customer communication
Press release, Copenhagen, 25 September 2020 Agillic, a leading Nordic omnichannel marketing software company, signs a contract with Danish telecom and broadband network supplier Dansk Kabel TV. With Agillic’s capability to integrate into a...
Sep 25, 2020 02:00 ET
Jyseleca® (filgotinib) approved in Japan for rheumatoid arthritis
Filgotinib demonstrates durable efficacy and consistent safety profile through 52 weeks in clinical trials Mechelen, Belgium; 25 September 2020, 08.00 CET – Galapagos NV (Euronext & NASDAQ: GLPG) reports that Gilead Sciences, Inc. (Nasdaq: GILD)...
Sep 25, 2020 01:30 ET
Availability of the Q3 2020 Memorandum for modelling purposes
Availability of the Q3 2020 Memorandum for modelling purposes Paris, France – September 25, 2020 - Sanofi announced today that its Q3 2020 Memorandum for modelling purposes is available on the "Investors" page of the company's website:...
Sep 25, 2020 01:00 ET
Q-Gold Announces Exploration Program at Past-Producing High-Grade Foley Gold Mine Complex, Ontario
Q-Gold Resources Ltd (TSXV: QGR) (“Q-Gold” or the “Company”) is pleased to announce its 2020-2021 exploration program at its wholly-owned Foley Gold Mine complex, near the town of Mine Centre, Ontario. Q-Gold will drill targets at the...
Sep 24, 2020 22:29 ET
Fluidigm Corporation Investors: Company Investigated by the Portnoy Law Firm
The Portnoy Law Firm advises Fluidigm Corporation ("Fluidigm" or the "Company") (NASDAQ: FLDM) investors that the firm has initiated an investigation into possible securities fraud, and may file a class action on behalf of investors. Investors are...
Sep 24, 2020 22:06 ET
Uniserve reports results for fiscal year ended May 31, 2020
Uniserve Communications Corporation (“Uniserve”) a provider of IT solutions and services to business and residential customers in Canada wishes to announce its annual fiscal 2020 financial results.   Revenues for fiscal 2020 were $12,359K as...
Sep 24, 2020 21:23 ET
GeoVax Announces Pricing of $12.8 Million Public Offering; Uplisting to Nasdaq and Reverse Stock Split
via NewMediaWire -- GeoVax Labs, Inc. (NasdaqCM: GOVX, GOVXW) (“GeoVax” or the “Company”), a biotechnology company developing human immunotherapies and vaccines against infectious diseases and cancer, today announced the pricing of its underwritten...
Sep 24, 2020 21:00 ET
INVESTOR ALERT: Kirby McInerney LLP Reminds Investors That a Class Action Lawsuit Has Been Filed Against Portland General Electric Company and Encourages Investors to Contact the Firm Before November
The law firm of Kirby McInerney LLP reminds investors that a class action lawsuit has been filed in the U.S. District Court for the District of Oregon on behalf of those who acquired Portland General Electric Company (“PGE” or the “Company”) (NYSE:...
Sep 24, 2020 21:00 ET
OliX Pharmaceuticals Announces IND Submission to U.S. FDA to Evaluate the Efficacy of OLX10010 in Phase 2a Clinical Trial
OliX Pharmaceuticals, Inc. (KOSDAQ: 226950), a leading developer of RNAi therapeutics, announced today the submission of an Investigational New Drug (IND) application to the US Food and Drug Administration (FDA) to evaluate the efficacy of OLX10010...
Sep 24, 2020 20:50 ET
Prelude Therapeutics Announces Pricing of Initial Public Offering
Prelude Therapeutics Incorporated (Nasdaq: PRLD), a clinical-stage precision oncology company, today announced the pricing of its initial public offering of 8,325,000 shares of its common stock at a public offering price of $19.00 per share. The...